Citation Impact
Citing Papers
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Predictors of opioid misuse in patients with chronic pain: a prospective cohort study
2006
Vismodegib
2012
Engineering precision nanoparticles for drug delivery
2020 Standout
Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands
2006 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines
2020
Use of liposomal anthracyclines in Kaposi’s sarcoma
2004
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients
2013
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis
1995
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
2005 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
AP-1: a double-edged sword in tumorigenesis
2003 Standout
Modulation of RXR function through ligand design
2011
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Small‐Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics
2010
Transcriptional Regulation of Metabolism
2006
Drug Binding in Plasma
1994
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
New Thrombopoietic Growth Factors
2009
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Central Hypothyroidism Associated with Retinoid X Receptor–Selective Ligands
1999
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
How were new medicines discovered?
2011 Standout
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Management of the patient with progressive radioiodine non-responsive disease
1999
The promise of retinoids to fight against cancer
2001
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs
1992
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice
2004
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Energy Metabolism in the Liver
2014 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Efficacy and Safety of a Once-Daily Morphine Formulation in Chronic, Moderate-to-Severe Osteoarthritis Pain
2002
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
2000
Hydrolysis and amino acid composition analysis of proteins
1998
Atherosclerosis
2001 Standout
Retinoids: present role and future potential
1999
Retinoid X Receptor Heterodimers in the Metabolic Syndrome
2005
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Chiral Brønsted acid catalyzed Friedel–Crafts alkylation reactions
2009 Standout
Oral Alitretinoin (9-cis-Retinoic Acid) Therapy for Chronic Hand Dermatitis in Patients Refractory to Standard Therapy
2004
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma
2007
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
β-Phenylethylamines and the isoquinoline alkaloids
2004
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
The Organocatalytic Approach to Enantiopure 2H‐ and 3H‐Pyrroles: Inhibitors of the Hedgehog Signaling Pathway
2016 StandoutNobel
Retinoic Acid and the Histone Deacetylase Inhibitor Trichostatin A Inhibit the Proliferation of Human Renal Cell Carcinoma in a Xenograft Tumor Model
2005
Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results
2001
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Biological Feedbacks in Global Desertification
1990 StandoutScience
Thyroid Hormone Regulation of Metabolism
2014 Standout
The Pharmacokinetics of Non-Steroidal Anti-Inflammatory Drugs in the Elderly
1987
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Cyclooxygenase in biology and disease
1998 Standout
Drug Disposition in Obese Humans
1986
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
2007 Standout
Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT II
2008
The Metabolic Syndrome
2008 Standout
Opioid Complications and Side Effects
2008 Standout
Cross-Dehydrogenative Coupling (CDC): Exploring C−C Bond Formations beyond Functional Group Transformations
2008 Standout
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
2001
Thyroid carcinoma
2003 Standout
Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview
2019
New agents for cancer chemoprevention
1996
Works of Gordon Loewen being referenced
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
2000
A phase I-II study of 9-cis retinoic acid and interferon-α2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Trials Group study
2000
Bioavailability of Intranasal vs. Rectal Diazepam
2012
Pharmacokinetic evaluation of a sprinkle-dose regimen of a once-daily, extended-release morphine formulation
2002
Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza™, and a Twice-Daily Controlled-Release Morphine Formulation in Patients with Chronic Moderate-to-Severe Pain
2002
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.
1997
High-Performance Liquid Chromatographic Method for the Simultaneous Quantitation of Diflunisal and its Glucuronide and Sulfate Conjugates in Human Urine
1989
Administration of Morphine Sulfate Extended-Release Capsules via Gastrostomy: Dissolution Study and Case Reports
2007
Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
1998
Steady-state pharmacokinetic comparison of a new, once-daily, extended-release morphine formulation (Morphelan™) and OxyContin® twice daily
2001
A Phase I study of LGD1069 in adults with advanced cancer.
1999
Single and Multiple Oral Doses of LGD-4665, a Small Molecule Thrombopoietin Receptor Agonist, Increase Platelet Counts in Healthy Male Subjects
2007
Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.
1996
A proof-of-principle trial of bexarotene in patients (pts) with resectable non-small cell lung cancer (NSCLC)
2005
Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs
1983
A phase I study of IPI-926, a novel hedgehog pathway inhibitor, in patients (pts) with advanced or metastatic solid tumors.
2011
(205) Steady-State Pharmacokinetic Comparison of MorphelanR ROERR (Morphine Sulfate Rapid Onset Extended Release) Once-a-Day and Morphine Oral Solution Administered Q4H around-the-Clock in Healthy Volunteers
2001
(205) Steady-State Pharmacokinetic Comparison of Morphelan® ROER® (Morphine Sulfate Rapid Onset Extended Release) Once-a-Day and Morphine Oral Solution Administered Q4H around-the-Clock in Healthy Volunteers
2001